All stock lists
Hyperfine, Inc. (NASDAQ:HYPR)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
0.72+0.00 (-0.14%)
Insider Score
––Not scored
HYPR Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
HYPR Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 3.90 M | 3.90 M | 5.29 M | 3.44 M | 2.70 M | 2.14 M |
| Revenue Growth (YoY) | 44.81 % | 82.64 % | 128.05 % | -5.65 % | -25.75 % | -35.14 % |
| Cost of Revenue | 1.92 M | 1.92 M | 2.60 M | 1.59 M | 1.37 M | 1.25 M |
| Gross Profit | 1.98 M | 1.98 M | 2.69 M | 1.85 M | 1.33 M | 883.00 K |
| SG&A Expense | 6.58 M | 6.69 M | 6.54 M | 6.72 M | 6.38 M | 6.75 M |
| R&D Expense | 3.87 M | 3.85 M | 3.83 M | 4.05 M | 4.54 M | 5.04 M |
| Operating Expenses | 10.45 M | 10.54 M | 10.36 M | 10.77 M | 10.92 M | 11.79 M |
| Operating Income | -8.47 M | -8.56 M | -7.67 M | -8.92 M | -9.60 M | -10.90 M |
| Pretax Income | -9.30 M | -8.62 M | -5.91 M | -11.02 M | -9.22 M | -9.42 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -9.30 M | -8.62 M | -5.91 M | -11.02 M | -9.22 M | -9.42 M |
| EPS (Basic) | -0.09 | -0.09 | -0.06 | -0.14 | -0.12 | -0.12 |
| EPS (Diluted) | -0.09 | -0.09 | -0.06 | -0.14 | -0.12 | -0.12 |
| Shares Outstanding | 99.80 M | 97.70 M | 94.20 M | 79.03 M | 78.08 M | 75.70 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.